May 8, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Luna DNA Raises $4 Million Including Key Investors Illumina Ventures and Arch Venture Partners

Funding supports company’s mission to launch a medical discovery platform and engage a global community of data contributors   SAN DIEGO, May 8, 2018 /PRNewswire/ — Luna DNA, the first community-owned genomic and medical research database, today announced financing from key investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader... Read more

May 8, 2018 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Greiner Bio-One acquires 3D Cell Culture Technology assets from Nano3D Biosciences, Inc.

08. May 2018 Greiner Bio-One Magnetic 3D Cell Culture Products Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide. Magnetic 3D... Read more

May 8, 2018 Clinical Research/Diagn. PR/Corporate Product Launch

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 08 May 2018 Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting New and updated pivotal combination data from the Tecentriq lung programme, including overall survival (OS) results from IMpower150 and progression free survival (PFS) results from IMpower131 New, longer follow-up data... Read more

May 8, 2018 Clinical Research/Diagn. PR/Corporate Product Launch

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 08 May 2018 Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting New and updated pivotal combination data from the Tecentriq lung programme, including overall survival (OS) results from IMpower150 and progression free survival (PFS) results from IMpower131 New, longer follow-up data... Read more

April 26, 2018 Clinical Research/Diagn. Lab Top-10

Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing

Agilent Expands Portfolio of In Situ Hybridization Probes for Clinical Testing Fully automated CISH and IQFISH panel for lymphoma combines multiple innovations SANTA CLARA, Calif., April 26, 2018 Agilent Technologies Inc. (NYSE: A) today announced an expansion of its portfolio of in situ hybridization probes with the release of its EBER RNA CISH, Kappa, and... Read more

April 25, 2018 Bio/Pharma/CRO Clinical Research/Diagn. Mass Spectrometry Product Launch

The Global Metabolomics Market (Forecast: 2017–2022)—Top Down Analytics

LOS ANGELES, April 25, 2018 (GLOBE NEWSWIRE) — Top-Down Analytics (TDA), a Los Angeles-  based market research and management consulting firm has announced a new market report entitled Metabolomics 2018: Charged with Massive Potential. Over the past five years, the market for metabolomics research has increased dramatically, with LC/MS and NMR leading the charge in... Read more

April 20, 2018 Clinical Research/Diagn. Lab Top-10

Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage

60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Addresses Clinical Need MADRID, April 20, 2018 /PRNewswire/ —  New CE-IVD FastSepsityper® solution: for MALDI-Biotyper (MBT) identification (ID) of over 2,700 microbial species from Positive Blood Cultures (PBC) with less hands-on time; Novel... Read more

April 19, 2018 Clinical Research/Diagn. Informatics & Software Liq. Handling & Robotics Product Launch

BD Unveils Suite of Diagnostic Informatics and Automation Innovations

FRANKLIN LAKES, N.J., April 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance. The new molecular, microbiology and software solutions will be showcased... Read more